[Conference presentation] Presenting at the Alzheimer’s Association International Conference 2026 (AAIC 2026)
- #Conference Presentations
Sysmex Corporation presented the latest data on the development of blood-based biomarkers for Alzheimer's disease at the Alzheimer’s Association International Conference 2026 (AAIC 2026), which held in London, United Kingdom, from July 12 to 15, 2026.
| Session | Subject | Presenter (Affiliation) |
|---|---|---|
Developing Topics: Biomarkers (Sunday-1219) | Validation of highly specific and automated immunoassays for endogenously cleaved MTBR-tau243 in CSF: a comparison with mass spectrometry*1 | Shun Murakami (Sysmex corporation) |
Developing Topics: Biomarkers (Sunday-1115) | Longitudinal changes in blood-based biomarkers of Alzheimer’s disease across age groups and their associations with cognitive function*2 | Kengo Ishiki (Sysmex corporation) |
| Session | Subject |
|---|---|
Developing Topics: Biomarkers (Sunday-1152) | Plasma endogeneously cleaved MTBR‑tau243 measured by an automated immunoassay is associated with tau PET–based Braak staging*3 |
| Session | Subject |
|---|---|
Developing Topics: Biomarkers (Tuesday-0311) | High diagnostic performance of the random-access HISCL pTau-217, Aβ42 and Aβ40 plasma assays in detecting amyloid pathology across clinical stages*4 |
- Terminology
- *1Co-presentation with Eisai Co., Ltd.
- *2Co-presentation with Shiga University of Medical Science
- *3Co-presentation with Tokyo Metropolitan Institute for Geriatrics and Gerontology
- *4Co-presentation with Amsterdam UMC
- *Information contained in the news is current as of the date of the announcement, but may be subject to change without prior notice.
